-

Form 8.3 - UDG Healthcare plc

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

  Name of person dealing (Note 1) Barclays PLC.
  Company dealt in UDG HEALTHCARE PLC
  Class of relevant security to which the  ORD
  dealings being disclosed relate (Note 2)
  Date of dealing 06 July 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD    
  Long Short
 

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

 

8,369,353

3.32%

445,550

0.18%

   

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

377,387

0.15%

7,510,016

2.98%

   

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

TOTAL:

 

 

 

 

 

8,746,740

3.47%

7,955,566

3.16%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

581

10.7049   GBP

Purchase

810

10.6900   GBP

Purchase

1,024

10.7014   GBP

Purchase

1,026

10.7100   GBP

Purchase

1,110

10.6950   GBP

Purchase

2,174

10.6985   GBP

Purchase

2,950

10.7015   GBP

Purchase

3,403

10.7000   GBP

Purchase

4,823

10.7045   GBP

Purchase

6,638

10.6988   GBP

Purchase

16,880

10.7094   GBP

Purchase

24,435

10.7053   GBP

Purchase

30,963

10.6994   GBP

Purchase

56,079

10.7110   GBP

Sale

1,982

10.6940   GBP

Sale

2,646

10.7000   GBP

Sale

2,921

10.6910   GBP

Sale

4,208

10.7012   GBP

Sale

4,904

10.6935   GBP

Sale

12,141

10.7001   GBP

Sale

17,026

10.7100   GBP

Sale

20,794

10.6975   GBP

Sale

61,527

10.7089   GBP

(b) Derivatives transactions (other than options transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per

 

 

 

unit

SWAP

Long

3,719

10.6924   GBP

CFD

Long

4,208

10.7017   GBP

SWAP

Long

4,546

10.6903   GBP

SWAP

Long

9,636

10.6934   GBP

SWAP

Short

16

10.7100   GBP

SWAP

Short

584

10.7005   GBP

SWAP

Short

2,311

10.7035   GBP

SWAP

Short

3,665

10.7099   GBP

CFD

Short

3,703

10.7014   GBP

SWAP

Short

36,009

10.7040   GBP

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

7 Jul 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected  
If a connected EFM, state nature of connection  

 

Contacts

BARCLAYS PLC

BARCLAYS PLC

LSE:UDG

Release Versions

Contacts

BARCLAYS PLC

More News From BARCLAYS PLC

BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - STAGECOACH GROUP PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...

BARCLAYS PLC UK Regulatory Announcement: FORM 8.3 - ULTRA ELECTRONICS HOLDINGS PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...

BARCLAYS PLC UK Regulatory Announcement: FORM 8.3 - VIVO ENERGY PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...
Back to Newsroom